Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and bms 433771

ribavirin has been researched along with bms 433771 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbott, E; Alber, DG; Baxter, RC; Bithell, SK; Carter, MC; Chambers, P; Chapman, J; Chubb, A; Cockerill, GS; Collins, PL; Dowdell, VC; Henderson, EA; Keegan, SJ; Kelsey, RD; Lockyer, MJ; Luongo, C; Najarro, P; Pickles, RJ; Powell, KL; Simmonds, M; Taylor, D; Tyms, S; Wilson, LJ1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1
Boido, V; Collu, G; Delogu, I; Giliberti, G; La Colla, P; Loddo, R; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M1

Other Studies

3 other study(ies) available for ribavirin and bms 433771

ArticleYear
RSV604, a novel inhibitor of respiratory syncytial virus replication.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Amino Acid Sequence; Antiviral Agents; Benzodiazepinones; Cell Line; Chemical Phenomena; Chemistry, Physical; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Epithelial Cells; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Nucleocapsid Proteins; Phenylurea Compounds; Respiratory Syncytial Viruses; Tetrazolium Salts; Virus Replication

2007
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5.
    Bioorganic & medicinal chemistry, 2015, Nov-01, Volume: 23, Issue:21

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cricetinae; DNA Viruses; Dogs; Enterovirus B, Human; Humans; RNA Viruses; Structure-Activity Relationship; Triazoles; Virus Replication

2015